Technetium (99mTc): Clinical Trials

3 trials of Technetium (99mTc), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting, 1 recruiting. 1 Not applicable, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable1Recruiting 1
Phase 31Not yet recruiting 1

Follow Technetium (99mTc): new trials by email Literature Review of Technetium (99mTc) trials Research Report on Technetium (99mTc)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Superparamagnetic Iron Oxide for Sentinel Lymph Node Localization in Patients With Cutaneous Melanoma: MagMen-II
Superparamagnetic Iron Oxide, Technetium (99mTc) - Melanoma (Skin Cancer)
Phase 3Not yet recruitingVastra Gotaland Region2542026-10-012026-09-03
Implementation of Indocyanine Green to Identify Sentinel Lymph Nodes During Surgery for Breast Cancer
Technetium (99mTc), Indocyanine Green, Sentinel lymph node biopsy - Breast Cancer, Sentinel Lymph Node Biopsy (SLNB)
Not applicableRecruitingIsabelle Henskens17602025-04-182026-06-25
A French Observational Study of Indocyanine Green for Patients With Breast Cancer Having a Sentinel Lymph Node Biopsy.
Sentinel lymph node identification, indocyanine green, methylene blue - Breast Cancer
CompletedBTG International Inc.1012023-06-062024-05-10

Conditions studied

Breast Neoplasms (2)  ·  Lymphatic Metastasis (1)  ·  Melanoma (1)

Sponsors

BTG International Inc. (1)  ·  Isabelle Henskens (1)  ·  Vastra Gotaland Region (1)

Countries

France (1)  ·  Netherlands (1)

Top investigators

Annemiek Doeksen, MD, PhD (1)

Results publications

PMID 42342397